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A key component of physician autonomy is our ability to give prognostic information to 
patients and families. But what happens when there are few scientific data to guide 
those predictions? This can be precarious and lead family to make life and death 
choices based on an ill-advised recommendation from a physician. Take the example of 
intracerebral hemorrhage (ICH). The literature is replete with studies suggesting high 
mortality following ICH, and prognostic scales that predict poor outcome based mostly 
on the size of the hematoma and how sleepy the patient is in the emergency 
department. For years, this led clinicians to make early withdrawal of care 
recommendations to family. Some researchers noted, however, that these ICH 
prognostic models were developed in patients that had early withdrawal of care1. This 
was a self-fulfilling prophecy; that is, if researchers developed a predictive model in 
patients whose care was withdrawn when they had large hematomas and were sleepy, 
then of course the model would show that hematoma size and Glasgow coma scale 
(GCS) score were predictive of ICH mortality. There is little doubt that patients with 
large hemorrhages and low GCS scores have a more difficult time to recover, but do we 
really know just what those chances are, especially if we do absolutely everything that a 
good neurocritical care unit can do?  
 
This question led to several studies that demonstrated that withdrawal of care was a 
potent independent risk factor for ICH death even after controlling for the usual clinical 
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predictors of bad ICH outcome2, 3. A multi-center study of 109 subjects even 
demonstrated that care limitations deferral for at least the first five days, and aggressive 
neurocritical care, is associated with an absolute ICH mortality reduction of 30% 
compared with ICH-score prediction, and that one third of subjects recover to better 
than moderate disability4. 
 
In this issue of the Annals, Parry-Jones, et al add to this growing literature by 
demonstrating a large survival benefit in ICH patients treated aggressively at a single 
hospital compared with outcomes reported in a National registry in the UK5. Their paper 
focuses on a “bundle” of treatments: reversal of coagulation status, referral to 
neurosurgery for some cases of ICH, blood pressure control and admission to a neuro 
ICU. The authors found a 6-12% absolute reduction in mortality during and after the 
intervention. Similar results were found in the quasi-experimental comparison to ICH 
patients in the UK registry. However, in a mediation analysis, a statistical way to 
estimate the role of a third variable in the association between the independent and 
dependent variables, none of the individual parts of the “bundle” were significantly 
associated with ICH mortality. Indeed, the factor that mediated more than 50% and was 
significantly associated with a survival benefit was a reduction in early do-not-
resuscitate orders. It seems that at the authors’ hospital, invoking the “bundle” 
motivated clinicians to aggressively treat patients and not give up too early. As the 
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authors note, this was not a clinical trial and the “bundle” or its individual components 
cannot be endorsed based solely on this work. Each component of the “bundle” has its 
own evidence-base and guideline comments6. The authors defend these particular 
interventions as “recommended” by the American Stroke Association ICH Guidelines, 
however, none of these are backed by Class I, Level of Evidence A support, and some 
such as referral to neurosurgery for hematomas >30 cc seem counter to statements 
from the Guideline, “For most patients with supratentorial ICH, the usefulness of surgery 
is not well established (Class IIb; Level of Evidence A).” The authors call for a cluster 
randomized clinical trial to test the “bundle.” I would argue that a trial of delaying care 
withdrawal in ICH is really the issue to be further investigated. This study also did not 
collect information on functional outcome, a critical issue when examining ICH 
outcomes. Most would agree that survival at the expense of severe disability is not the 
goal. 
 
While it is true that there remains no specific treatment for ICH, it appears that outcome 
can vary tremendously based on the aggressiveness of care provided. An unfortunate 
outcome of physician autonomy is the difficulty we have of admitting uncertainty. 
Personally, with each passing year from residency I feel less confident in making ICH 
clinical predictions because the range of outcomes I’ve seen are so varied. We also 
tend to blame families for these capricious, but life-determining decisions while it is clear 
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that we greatly influence these decisions. So, if I have an ICH, I am not sure that I want 
the “bundle,” but I am sure that I want a group of clinicians from the emergency 
department to the neurocritical care unit that will admit prognostic uncertainty, and 
agree to aggressively treat me until the eventual outcome becomes more obvious.      
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